CDKN2A and neurofibroma: At least 2 of 4 features with or without CDKN2A/B inactivationa: (a) cytologic atypia, (b) loss of neurofibroma architecture, (c) hypercellularity, or (d) mitotic index > 1/50 HPFs and <3/10 HPFs